DuBois, M.; Tseng, A.; Francis, S.M.; Haynos, A.F.; Peterson, C.B.; Jacob, S.
Utility of Downstream Biomarkers to Assess and Optimize Intranasal Delivery of Oxytocin. Pharmaceutics 2022, 14, 1178.
https://doi.org/10.3390/pharmaceutics14061178
AMA Style
DuBois M, Tseng A, Francis SM, Haynos AF, Peterson CB, Jacob S.
Utility of Downstream Biomarkers to Assess and Optimize Intranasal Delivery of Oxytocin. Pharmaceutics. 2022; 14(6):1178.
https://doi.org/10.3390/pharmaceutics14061178
Chicago/Turabian Style
DuBois, Megan, Angela Tseng, Sunday M. Francis, Ann F. Haynos, Carol B. Peterson, and Suma Jacob.
2022. "Utility of Downstream Biomarkers to Assess and Optimize Intranasal Delivery of Oxytocin" Pharmaceutics 14, no. 6: 1178.
https://doi.org/10.3390/pharmaceutics14061178
APA Style
DuBois, M., Tseng, A., Francis, S. M., Haynos, A. F., Peterson, C. B., & Jacob, S.
(2022). Utility of Downstream Biomarkers to Assess and Optimize Intranasal Delivery of Oxytocin. Pharmaceutics, 14(6), 1178.
https://doi.org/10.3390/pharmaceutics14061178